192 followers
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic #leukemia. #ALL https://t.co/ryxpKFADHV
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic #leukemia. #ALL https://t.co/ryxpKFADHV